Literature DB >> 7953980

Permeabilization of cells of hemopoietic origin by extracellular ATP4-: elimination of osteoclasts, macrophages, and their precursors from isolated bone cell populations and fetal bone rudiments.

W E Modderman1, A F Weidema, T Vrijheid-Lammers, A M Wassenaar, P J Nijweide.   

Abstract

Skeletal tissues contain, apart from cells of the osteogenic and chondrogenic lineage, cells of hemopoietic origin, e.g., macrophages, osteoclasts, and their precursors. In the present study we examined the sensitivity for extracellular ATP4- of the above-mentioned cell types in freshly isolated, bone-derived cell populations and in explanted fetal metatarsal bones. Cells of hemopoietic origin reacted to the presence of ATP4- with an increased permeability for impermeant cytotoxic molecules, e.g., ethidium bromide (EB), thiocyanate (KSCN), and an increased non-ion selective membrane conductance. As a consequence, these cells could be killed by a short treatment with adenosine-5' triphosphate (ATP)+KSCN. On the other hand, cells of nonhemopoietic origin (e.g., osteoblasts, chondrocytes) were found to be insensitive to ATP4- in this respect. These cells survived the treatment without apparent damage to their alkaline phosphatase activities, osteogenic potentials, and osteoclast induction capacities. The elimination of the endogenous cells of hemopoietic origin from bone tissue or cell populations derived therefrom offers the possibility to study the properties and functions of osteogenic or chondrogenic cells without interference by the presence of cells of hemopoietic origin. It also allows the study of interactions between osteogenic cells and selected cell populations of hemopoietic origin in coculture experiments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7953980     DOI: 10.1007/BF00297190

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  41 in total

1.  Extracellular nucleotides elevate [Ca2+]i in rat osteoblastic cells by interaction with two receptor subtypes.

Authors:  W J Reimer; S J Dixon
Journal:  Am J Physiol       Date:  1992-11

2.  Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages.

Authors:  S S Sung; J D Young; A M Origlio; J M Heiple; H R Kaback; S C Silverstein
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; T Sasaki; A Yamaguchi; H Kodama; T J Martin; T Suda
Journal:  Endocrinology       Date:  1989-10       Impact factor: 4.736

Review 5.  Extracellular ATP as a possible mediator of cell-mediated cytotoxicity.

Authors:  F Di Virgilio; P Pizzo; P Zanovello; V Bronte; D Collavo
Journal:  Immunol Today       Date:  1990-08

6.  Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells.

Authors:  N Takahashi; T Akatsu; T Sasaki; G C Nicholson; J M Moseley; T J Martin; T Suda
Journal:  Endocrinology       Date:  1988-09       Impact factor: 4.736

7.  Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.

Authors:  T Yamashita; K Asano; N Takahashi; T Akatsu; N Udagawa; T Sasaki; T J Martin; T Suda
Journal:  J Cell Physiol       Date:  1990-12       Impact factor: 6.384

8.  Rat mast cells permeabilized with ATP secrete histamine in response to calcium ions buffered in the micromolar range.

Authors:  J P Bennett; S Cockcroft; B D Gomperts
Journal:  J Physiol       Date:  1981-08       Impact factor: 5.182

9.  Involvement of guanine nucleotide-binding protein in the gating of Ca2+ by receptors.

Authors:  B D Gomperts
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

10.  Adenosine triphosphate can maintain multipotent haemopoietic stem cells in the absence of interleukin 3 via a membrane permeabilization mechanism.

Authors:  A D Whetton; S J Huang; P N Monk
Journal:  Biochem Biophys Res Commun       Date:  1988-05-16       Impact factor: 3.575

View more
  7 in total

Review 1.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

2.  Extracellular nucleotides activate non-selective cation and Ca(2+)-dependent K+ channels in rat osteoclasts.

Authors:  A F Weidema; J Barbera; S J Dixon; S M Sims
Journal:  J Physiol       Date:  1997-09-01       Impact factor: 5.182

3.  The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro.

Authors:  Ankita Agrawal; Katherine A Buckley; Keith Bowers; Mark Furber; James A Gallagher; Alison Gartland
Journal:  Purinergic Signal       Date:  2010-04-21       Impact factor: 3.765

4.  Expression, signaling, and function of P2X7 receptors in bone.

Authors:  Matthew W Grol; Nattapon Panupinthu; Jasminka Korcok; Stephen M Sims; S Jeffrey Dixon
Journal:  Purinergic Signal       Date:  2009-02-18       Impact factor: 3.765

Review 5.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

6.  P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis.

Authors:  Ning Wang; Ankita Agrawal; Niklas Rye Jørgensen; Alison Gartland
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

Review 7.  Extracellular ATP: A Feasible Target for Cancer Therapy.

Authors:  Valentina Vultaggio-Poma; Alba Clara Sarti; Francesco Di Virgilio
Journal:  Cells       Date:  2020-11-17       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.